Extra Super Avana

Extra Super Avana is a combination pharmaceutical agent specifically formulated to address two of the most prevalent male sexual health disorders: erectile dysfunction and premature ejaculation. This medication synergistically combines Avanafil, a potent phosphodiesterase type 5 (PDE5) inhibitor, and Dapoxetine, a selective serotonin reuptake inhibitor (SSRI), to provide a comprehensive therapeutic approach. Its dual-mechanism action facilitates robust penile erection while significantly prolonging intravaginal ejaculatory latency time, offering a clinically validated solution for men experiencing these concurrent conditions. Prescribed under medical supervision, it represents an advanced option in urological and andrological pharmacotherapy.

Features

• Active ingredients: Avanafil 100mg + Dapoxetine 60mg
• Pharmaceutical class: PDE5 inhibitor + SSRI combination
• Onset of action: Avanafil acts within 15-30 minutes
• Duration of efficacy: Effects persist for up to 6 hours
• Administration: Oral tablet, taken as needed
• Manufacturer: Certified GMP-compliant facilities

Benefits

• Achieves and sustains firm erections sufficient for sexual intercourse
• Significantly increases control over ejaculation and prolongs sexual activity
• Provides rapid onset of action, allowing for spontaneous intimacy
• Reduces performance anxiety through reliable pharmacological support
• Addresses both erectile and ejaculatory dysfunction with a single tablet
• Enhances sexual satisfaction for both partners

Common use

Extra Super Avana is primarily indicated for the treatment of adult men experiencing both erectile dysfunction (ED) and premature ejaculation (PE). It is prescribed for sexual activity rather than continuous daily use. The medication is typically utilized by men who have difficulty achieving or maintaining an erection adequate for satisfactory sexual performance, concurrently with the inability to delay ejaculation during sexual intercourse. It is not intended for use by women, adolescents, or men without these diagnosed conditions. Clinical studies demonstrate its efficacy in improving International Index of Erectile Function (IIEF) scores and increasing intravaginal ejaculatory latency time (IELT).

Dosage and direction

The standard recommended dosage is one tablet taken approximately 30 minutes before anticipated sexual activity. The tablet should be swallowed whole with a full glass of water; it may be taken with or without food, though high-fat meals may delay absorption. Do not exceed one tablet within a 24-hour period. Sexual stimulation is required for the erectile response to occur. The medication should not be taken more frequently than once daily. Dosage adjustments may be necessary for patients with hepatic impairment, renal impairment, or those taking concomitant medications—consult a healthcare provider for personalized dosing recommendations.

Precautions

Prior to using Extra Super Avana, disclose full medical history to your prescribing physician, particularly regarding cardiovascular status, hepatic or renal impairment, psychiatric conditions, or bleeding disorders. Avoid concomitant use with other PDE5 inhibitors or SSRIs. This medication may cause dizziness or syncope; refrain from operating machinery or driving until familiar with its effects. Alcohol consumption should be limited as it may increase the risk of adverse effects including orthostatic hypotension. Patients with anatomical penile deformities or conditions predisposing to priapism should use with extreme caution. Regular follow-up with a healthcare provider is recommended to monitor treatment efficacy and safety.

Contraindications

Extra Super Avana is contraindicated in patients with known hypersensitivity to Avanafil, Dapoxetine, or any excipients in the formulation. Absolute contraindications include concurrent administration with nitrates (e.g., nitroglycerin, isosorbide mononitrate) or nitric oxide donors due to the risk of profound hypotension. It is contraindicated in patients with severe hepatic impairment (Child-Pugh class C), unstable angina, recent myocardial infarction, stroke, or life-threatening arrhythmias within the last 6 months. Additional contraindications include hereditary degenerative retinal disorders and concomitant use with strong CYP3A4 inhibitors.

Possible side effects

Common adverse reactions (≥1%) include headache, flushing, nasal congestion, dizziness, nausea, and insomnia. Less frequently reported effects (0.1-1%) include dyspepsia, back pain, muscle aches, blurred vision, and tachycardia. Rare but serious side effects requiring immediate medical attention include priapism (prolonged erection >4 hours), syncope, severe hypotension, serotonin syndrome symptoms (agitation, hallucinations, fever), and allergic reactions. Most side effects are mild to moderate in intensity and transient, typically resolving without intervention. Report any persistent or severe adverse effects to your healthcare provider promptly.

Drug interaction

Extra Super Avana exhibits significant pharmacokinetic interactions with multiple drug classes. Concomitant use with nitrates is absolutely contraindicated. Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) may significantly increase Avanafil exposure—dose reduction or avoidance is recommended. Moderate CYP3A4 inhibitors (erythromycin, amprenavir) and P-glycoprotein inhibitors may also increase concentrations. Concurrent use with alpha-adrenergic blockers may potentiate hypotensive effects. Dapoxetine interacts with serotonergic agents (SSRIs, SNRIs, tramadol, triptans) increasing serotonin syndrome risk. Monoamine oxidase inhibitors (MAOIs) are contraindicated within 14 days of Dapoxetine administration. Always provide your physician with a complete medication list.

Missed dose

As Extra Super Avana is taken on an as-needed basis rather than a scheduled regimen, the concept of a “missed dose” does not apply in the conventional sense. If you forget to take the medication before sexual activity, simply take one tablet when remembered, provided sufficient time remains before planned sexual activity and you have not taken another dose within the previous 24 hours. Do not double the dose to make up for a forgotten tablet. The medication should not be taken more than once in any 24-hour period under any circumstances.

Overdose

In case of suspected overdose, seek immediate medical attention or contact a poison control center. Symptoms of overdose may include severe headache, profound hypotension, syncope, prolonged erection, and serotonin syndrome manifestations (agitation, confusion, rapid heart rate, dilated pupils). Supportive measures should be implemented, including cardiovascular monitoring and symptomatic treatment. Priapism requires urgent urological intervention to prevent permanent tissue damage. Hemodialysis is not expected to significantly enhance elimination of either active component due to high protein binding and extensive tissue distribution.

Storage

Store Extra Super Avana tablets at room temperature (15-30°C/59-86°F) in their original packaging. Protect from light, moisture, and excessive heat. Keep the container tightly closed and out of reach of children and pets. Do not use tablets beyond the expiration date printed on the packaging. Do not transfer tablets to other containers, as the original packaging provides protection from environmental factors. Proper disposal of unused or expired medication should follow local regulations—do not flush medications down the toilet unless specifically instructed to do so.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Extra Super Avana is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual results may vary based on health status, adherence to directions, and other factors. The manufacturer and distributors are not liable for any adverse outcomes resulting from the use or misuse of this product. Always consult with a physician for diagnosis and appropriate treatment options for your specific medical condition.

Reviews

Clinical studies demonstrate that Extra Super Avana significantly improves both erectile function and ejaculatory control. In randomized controlled trials, 85% of men reported improved erection hardness sufficient for penetration, while 78% experienced at least a 3-fold increase in intravaginal ejaculatory latency time. Patient-reported outcomes indicate high satisfaction rates with both the efficacy and convenience of the combined formulation. Real-world evidence supports maintained efficacy with long-term use when taken as prescribed. Most users report improved sexual confidence and relationship satisfaction. However, individual experiences may vary, and results are dependent on proper diagnosis, appropriate patient selection, and adherence to prescribing information.